Back to search results

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Abroad (travel likely)RecruitingPHASE3

Conditions

Regional Citrate Anticoagulation (RCA) · Continuous Renal Replacement Therapy (CRRT) · Acute Kidney Injury (AKI)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Alabama at Birmingham/UAB, Birmingham, Alabama, United States

    Contact: Principal Investigator (Eric Judd, MD)

  • University of Southern California (USC) / Keck Hospital, Los Angeles, California, United States

    Contact: Study coordinator (Gina Kucherepa) · Gina.kucherepa@med.usc.edu
    Contact: Study coordinator (Carolina Unizony) · carolina.unizony@med.usc.edu
    Contact: Principal Investigator (Fadi Tohme, MD)

  • University of California Los Angeles, Los Angeles, California, United States

  • University of Miami, Miami, Florida, United States

    Contact: Principal Investigator (Juan Duque, MD)

  • Emory University, Atlanta, Georgia, United States

    Contact: Principal Investigator (Michael J Connor Jr., MD)

  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Principal Investigator (Lenar Yessayan, MD)

  • Bon Secours Mercy Health-Springfield Regional Medical Center, Springfield, Ohio, United States

  • Geisinger Medical Center, Danville, Pennsylvania, United States

  • Penn State Hershey Medical Center, Hershey, Pennsylvania, United States

  • VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina (MUSC), Charleston, South Carolina, United States

    Contact: Study coordinator (Angela Francisco) · millare@musc.edu
    Contact: Principal Investigator (Blaithin McMahon, MD)

  • Lt. Col. Luke Weathers, Jr. VA Medical Center, Memphis, Tennessee, United States

    Contact: Study coordinator (Lillie Johnson) · Lillie.johnson3@va.gov
    Contact: Principal Investigator (Geeta Gyamlani, MD)

  • Methodist Dallas Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Sophie He) · SophieHe@mhd.com
    Contact: Principal Investigator (Roberto Collazo-Maldonado, MD)

  • Gamma Medical Research, Inc / McAllen Medical Center, McAllen, Texas, United States

View source on ClinicalTrials.gov(opens in a new tab)